220 related articles for article (PubMed ID: 38678269)
1. The effect of adipose-derived mesenchymal stem cell transplantation on ovarian mitochondrial dysfunction in letrozole-induced polycystic ovary syndrome in rats: the role of PI3K-AKT signaling pathway.
Abdi A; Ranjbaran M; Amidi F; Akhondzadeh F; Seifi B
J Ovarian Res; 2024 Apr; 17(1):91. PubMed ID: 38678269
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue.
Rabah HM; Mohamed DA; Mariah RA; Abd El-Khalik SR; Khattab HA; AbuoHashish NA; Abdelsattar AM; Raslan MA; Farghal EE; Eltokhy AK
Redox Rep; 2023 Dec; 28(1):2160569. PubMed ID: 36661246
[TBL] [Abstract][Full Text] [Related]
3. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway.
Liu M; Zhu H; Zhu Y; Hu X
J Ethnopharmacol; 2021 Apr; 270():113821. PubMed ID: 33460753
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS).
Atef MM; Abd-Ellatif RN; Emam MN; Abo El Gheit RE; Amer AI; Hafez YM
Arch Biochem Biophys; 2019 Aug; 671():245-254. PubMed ID: 31251923
[TBL] [Abstract][Full Text] [Related]
5. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
6. Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet.
Peng MF; Tian S; Song YG; Li CX; Miao MS; Ren Z; Li M
J Ethnopharmacol; 2021 Jun; 273():113947. PubMed ID: 33617969
[TBL] [Abstract][Full Text] [Related]
7. Curcumin Alleviates Hyperandrogenism and Promotes Follicular Proliferation in Polycystic Ovary Syndrome Rats: Insights on IRS1/PI3K/GLUT4 and PTEN Modulations.
Zheng L; Chen PF; Dai WC; Zheng ZQ; Wang HL
Chin J Integr Med; 2022 Dec; 28(12):1088-1095. PubMed ID: 36327049
[TBL] [Abstract][Full Text] [Related]
8. The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways.
Ye Y; Zhou W; Ren Y; Lu J; Chen A; Jin R; Xuan F
Gynecol Endocrinol; 2023 Dec; 39(1):2254848. PubMed ID: 37706434
[TBL] [Abstract][Full Text] [Related]
9. Improvement of the folliculogenesis by transplantation of bone marrow mesenchymal stromal cells in mice with induced polycystic ovary syndrome.
Kalhori Z; Azadbakht M; Soleimani Mehranjani M; Shariatzadeh MA
Cytotherapy; 2018 Dec; 20(12):1445-1458. PubMed ID: 30523787
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.
Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S
Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999
[TBL] [Abstract][Full Text] [Related]
11. Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress.
Huang Y; Zhang X
Am J Physiol Endocrinol Metab; 2021 Jun; 320(6):E1085-E1092. PubMed ID: 33900851
[TBL] [Abstract][Full Text] [Related]
12. Chinese herbal medicine alleviates the pathogenesis of polycystic ovary syndrome by improving oxidative stress and glucose metabolism via mitochondrial Sirtuin 3 signaling.
Zhang Q; Ren J; Wang F; Li M; Pan M; Zhang H; Qu F
Phytomedicine; 2023 Jan; 109():154556. PubMed ID: 36610149
[TBL] [Abstract][Full Text] [Related]
13. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098
[TBL] [Abstract][Full Text] [Related]
14. Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: Insights on PI3K/AkT/mTOR and TNF-α modulations.
Abuelezz NZ; Shabana ME; Abdel-Mageed HM; Rashed L; Morcos GNB
Life Sci; 2020 Sep; 256():118003. PubMed ID: 32589998
[TBL] [Abstract][Full Text] [Related]
15. Quercitrin alleviates lipid metabolism disorder in polycystic ovary syndrome-insulin resistance by upregulating PM20D1 in the PI3K/Akt pathway.
Li M; Gao S; Kang M; Zhang X; Lan P; Wu X; Yan X; Dang H; Zheng J
Phytomedicine; 2023 Aug; 117():154908. PubMed ID: 37321077
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K/AKT pathway.
Yu J; Ding C; Hua Z; Jiang X; Wang C
J Obstet Gynaecol Res; 2021 May; 47(5):1789-1803. PubMed ID: 33709493
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin D on experimental model of polycystic ovary syndrome in female rats.
Helal BAF; Ismail GM; Nassar SE; Zeid AAA
Life Sci; 2021 Oct; 283():119558. PubMed ID: 33930367
[TBL] [Abstract][Full Text] [Related]
18. Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome.
Bukke SPN; Pathange BBR; Karumanchi SK; Marri J; Boyina R; Rachamsetty K; Manchikalapati B; Odoma S; Hussaini B
J Ovarian Res; 2023 Nov; 16(1):221. PubMed ID: 37993900
[TBL] [Abstract][Full Text] [Related]
19. The effect of sitagliptin combined with rosiglitazone on autophagy and inflammation in polycystic ovary syndrome by regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway.
Ren Y; Ye Y; Xuan F; Chen A; Jin R; Zhou W; Lu J
Reprod Biol; 2023 Jun; 23(2):100763. PubMed ID: 37075562
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
